Abstract

ObjectivesCurrent standard of care for patients with stage IIIc epithelial ovarian cancer (EOC) is cytoreduction and intravenous (IV) chemotherapy. Intraperitoneal (IP) chemotherapy is considered superior to standard IV chemotherapy. Recent...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call